Prince Pharmaceutical Balance Sheet Health
Financial Health criteria checks 2/6
Prince Pharmaceutical has a total shareholder equity of NT$743.3M and total debt of NT$348.1M, which brings its debt-to-equity ratio to 46.8%. Its total assets and total liabilities are NT$1.4B and NT$619.2M respectively.
Key information
46.8%
Debt to equity ratio
NT$348.14m
Debt
| Interest coverage ratio | n/a |
| Cash | NT$100.29m |
| Equity | NT$743.33m |
| Total liabilities | NT$619.20m |
| Total assets | NT$1.36b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 6935's short term assets (NT$358.5M) exceed its short term liabilities (NT$210.3M).
Long Term Liabilities: 6935's short term assets (NT$358.5M) do not cover its long term liabilities (NT$408.9M).
Debt to Equity History and Analysis
Debt Level: 6935's net debt to equity ratio (33.3%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if 6935's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: 6935's debt is not well covered by operating cash flow (18.7%).
Interest Coverage: Insufficient data to determine if 6935's interest payments on its debt are well covered by EBIT.